Sixiang Shi

This study demonstrates that FOLR1-targeted Actinium-225 alpha-particle therapy effectively treats ovarian cancer with high tumor regression and survival rates while minimizing toxicity.

The paper develops radiotracers for CD47/SIRPα axis imaging and evaluates their biodistribution in mice, showing potential for optimizing therapeutic strategies.

The paper shows that CuS nanoparticle-mediated photothermolysis of ovarian cancer cells enhances dendritic cell activation and T cell expansion compared to ionizing radiation.

This study shows that targeting mitochondrial metabolism with Atovaquone enhances radiotherapy effectiveness in pediatric rhabdoid tumors by improving tumor oxygenation.